Literature DB >> 18695297

Measurement of dose reductions for superficial x-rays backscattered from bone interfaces.

Martin J Butson1, Tsang Cheung, Peter K N Yu.   

Abstract

Accurate measurement and knowledge of dose delivered during superficial x-ray radiotherapy is required for patient dose assessment. Some tumours treated near the surface (within the first few centimetres) can have large posterior bone structures. This can cause perturbations to dose delivered due to changed backscatter contributions from the bony structure as compared to full water or tissue scattering conditions. Measured results have shown that up to 7.5% of Dmax reductions in dose can occur near the water/bone interface for 100 kVp, using 10 cm diameter field sizes when a 1 cm thick slab of bone is located at 2 cm depth. At smaller field sizes such as 2 cm diameter these values reduce to 2% for the same energy. Larger variations (up to 12.5% of maximum) have been seen at the phantom surface when the bone layer is directly behind the point of interest (within 0.5 mm) and smaller effects (up to 5% of maximum) at depths down to 5 cm. Interesting to note is the fact that for larger field sizes, an increase in percentage dose is found at the water/bone interface due to the production of low energy backscattered electrons similar to the effect found in lead. However, they are much smaller in magnitude and thus would not cause any significant dosimetric effects. In the case where large bony structures lie relatively close to the surface and the tissue above this region is being treated, a dosimeter such as radiochromic film can be used to estimate the dose reduction that may occur due to the changed backscatter conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18695297     DOI: 10.1088/0031-9155/53/17/N01

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  5 in total

1.  DEGRO practical guidelines for radiotherapy of non-malignant disorders: Part I: physical principles, radiobiological mechanisms, and radiogenic risk.

Authors:  Berthold Reichl; Andreas Block; Ulrich Schäfer; Christoph Bert; Reinhold Müller; Horst Jung; Franz Rödel
Journal:  Strahlenther Onkol       Date:  2015-06-28       Impact factor: 3.621

2.  Use of calculations to validate beam quality and relative dose measurements for a kilovoltage X-ray therapy unit.

Authors:  B J Healy; R F Hill
Journal:  Phys Eng Sci Med       Date:  2022-04-05

Review 3.  Review of backscatter measurement in kilovoltage radiotherapy using novel detectors and reduction from lack of underlying scattering material.

Authors:  David J Eaton; Paul J Doolan
Journal:  J Appl Clin Med Phys       Date:  2013-11-08       Impact factor: 2.102

4.  Evaluation of Dosimetric Effect of Bone Scatter on Nanoparticle-Enhanced Orthovoltage Radiotherapy: A Monte Carlo Phantom Study.

Authors:  Afia Sadiq; James C L Chow
Journal:  Nanomaterials (Basel)       Date:  2022-08-29       Impact factor: 5.719

5.  Surface dose reduction from bone interface in kilovoltage X-ray radiation therapy: a Monte Carlo study of photon spectra.

Authors:  James C L Chow; Amir M Owrangi
Journal:  J Appl Clin Med Phys       Date:  2012-09-06       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.